Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Mediation of multi-drug resistance in a Chinese hamster ovary cell line by a mutant type II topoisomeraseB S Glisson, D M Sullivan, R Gupta, et al.
Cancer Research|October 1, 1985
Effects of verapamil on etoposide, vincristine, and adriamycin activity in normal human bone marrow granulocyte-macrophage progenitors and in human K562 leukemia cells in vitroJ C Yalowich, J R Zucali, M Gross, et al.
Cancer Research|February 1, 1984
Inhibition of etoposide-induced DNA damage and cytotoxicity in L1210 cells by dehydrogenase inhibitors and other agentsA J Wozniak, B S Glisson, K R Hande, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Role of proliferation in determining sensitivity to topoisomerase II-active chemotherapy agentsD M Sullivan, K C Chow, B S Glisson, et al.
Cancer Treatment Reports|February 1, 1982
Potentiation of bleomycin toxicity by oxygenC H Toledo, W E Ross, C I Hood, et al.
Biochemistry|June 27, 1989
Purification and characterization of an altered topoisomerase II from a drug-resistant Chinese hamster ovary cell lineD M Sullivan, M D Latham, T C Rowe, et al.
Molecular and Cellular Biology|August 1, 1989
Depletion of topoisomerase II in isolated nuclei during a glucose-regulated stress responseJ W Shen, J R Subjeck, R B Lock, et al.
Biochimica Et Biophysica Acta|November 17, 1983
Properties of a purified nuclear topoisomerase from L1210 cellsC F Ross, M J Brougham, W K Holloman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Inhibition of topoisomerases by fredericamycin AM D Latham, C K King, P Gorycki, et al.
Cancer Treatment Reports|March 1, 1984
Probenecid inhibition of methotrexate cytotoxicity in mouse L1210 leukemia cellsD Gangji, W E Ross, W A Bleyer, et al.
Pageof 7